DK1635843T3 - Terapi, der omfatter dienogest for hormonerstatning og depression - Google Patents
Terapi, der omfatter dienogest for hormonerstatning og depressionInfo
- Publication number
- DK1635843T3 DK1635843T3 DK04744181T DK04744181T DK1635843T3 DK 1635843 T3 DK1635843 T3 DK 1635843T3 DK 04744181 T DK04744181 T DK 04744181T DK 04744181 T DK04744181 T DK 04744181T DK 1635843 T3 DK1635843 T3 DK 1635843T3
- Authority
- DK
- Denmark
- Prior art keywords
- dienogest
- depression
- therapy
- hormone replacement
- hormone
- Prior art date
Links
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 title abstract 2
- 229960003309 dienogest Drugs 0.000 title abstract 2
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 1
- 238000011260 co-administration Methods 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Surface Treatment Of Glass Fibres Or Filaments (AREA)
- Lubricants (AREA)
- Injection Moulding Of Plastics Or The Like (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48215403P | 2003-06-25 | 2003-06-25 | |
US48843903P | 2003-07-21 | 2003-07-21 | |
PCT/IB2004/002535 WO2004112797A1 (en) | 2003-06-25 | 2004-06-25 | Hormone replacement- and depression therapy comprising dienogest |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1635843T3 true DK1635843T3 (da) | 2009-05-04 |
Family
ID=33544504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04744181T DK1635843T3 (da) | 2003-06-25 | 2004-06-25 | Terapi, der omfatter dienogest for hormonerstatning og depression |
Country Status (11)
Country | Link |
---|---|
US (2) | US20050032758A1 (da) |
EP (1) | EP1635843B1 (da) |
JP (1) | JP2007528358A (da) |
AT (1) | ATE419855T1 (da) |
DE (1) | DE602004018921D1 (da) |
DK (1) | DK1635843T3 (da) |
ES (1) | ES2320662T3 (da) |
PL (1) | PL1635843T3 (da) |
PT (1) | PT1635843E (da) |
SI (1) | SI1635843T1 (da) |
WO (1) | WO2004112797A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004019743B4 (de) * | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
BRPI0511569A (pt) * | 2004-05-26 | 2008-01-02 | Wyeth Corp | composições e métodos para o tratamento de distúrbio disfórico pré-menstrual |
EP1774970A1 (de) * | 2005-10-13 | 2007-04-18 | Bayer Schering Pharma AG | Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest |
US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
WO2010075175A1 (en) * | 2008-12-23 | 2010-07-01 | Quest Diagnostics Investments Incorporated | Mass spectrometry assay for estrogenic compounds |
BE1027858B1 (fr) * | 2019-12-13 | 2021-07-14 | Georges Debled | Composition pharmaceutique pour la contraception chez la femme |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US165209A (en) * | 1875-07-06 | Improvement in automatic shut-off attachments for water-closets | ||
US198671A (en) * | 1877-12-25 | Improvement in apparatus for recovering alkali from waste solutions | ||
DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
WO1998004269A1 (en) * | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen |
US6306914B1 (en) * | 1997-10-21 | 2001-10-23 | Columbia Laboratories, Inc. | Progestin therapy for maintaining amenorrhea |
CA2267743C (en) * | 1999-03-30 | 2011-07-26 | Robert F. Casper | Low dose estrogen interrupted hormone replacement therapy |
US8026228B2 (en) * | 2001-11-15 | 2011-09-27 | Pantarhei Bioscience B.V. | Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
AU2003213956A1 (en) * | 2002-04-03 | 2003-10-13 | Jencap Research Ltd. | Improved hormone replacement therapy |
-
2004
- 2004-06-25 PT PT04744181T patent/PT1635843E/pt unknown
- 2004-06-25 SI SI200431086T patent/SI1635843T1/sl unknown
- 2004-06-25 AT AT04744181T patent/ATE419855T1/de active
- 2004-06-25 JP JP2006516611A patent/JP2007528358A/ja active Pending
- 2004-06-25 US US10/875,521 patent/US20050032758A1/en not_active Abandoned
- 2004-06-25 EP EP04744181A patent/EP1635843B1/en not_active Not-in-force
- 2004-06-25 WO PCT/IB2004/002535 patent/WO2004112797A1/en active Application Filing
- 2004-06-25 ES ES04744181T patent/ES2320662T3/es active Active
- 2004-06-25 PL PL04744181T patent/PL1635843T3/pl unknown
- 2004-06-25 DK DK04744181T patent/DK1635843T3/da active
- 2004-06-25 DE DE602004018921T patent/DE602004018921D1/de active Active
-
2012
- 2012-03-02 US US13/411,131 patent/US20120225853A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1635843B1 (en) | 2009-01-07 |
JP2007528358A (ja) | 2007-10-11 |
SI1635843T1 (sl) | 2009-06-30 |
DE602004018921D1 (de) | 2009-02-26 |
ES2320662T3 (es) | 2009-05-27 |
WO2004112797A1 (en) | 2004-12-29 |
US20050032758A1 (en) | 2005-02-10 |
US20120225853A1 (en) | 2012-09-06 |
PT1635843E (pt) | 2009-04-07 |
EP1635843A1 (en) | 2006-03-22 |
PL1635843T3 (pl) | 2009-06-30 |
ATE419855T1 (de) | 2009-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
WO2002092102A3 (en) | Treatment of conditions relating to hormone deficiencies by administration of progestins | |
DK1363641T3 (da) | Progestagen, der er co-mikroniseret med et overfladeaktivt middel, farmaceutisk præparat, som indeholder det, fremgangsmåder til fremstilling deraf samt anvendelser deraf | |
EP1906968A4 (en) | NEW SCHEMES FOR ORAL MONOPHASIC CONTRAZEPTIVA | |
HK1099228A1 (en) | Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis | |
HK1078588A1 (en) | Process to prepare eplerenone | |
NO20044898L (no) | Nye etonogestrel estere | |
MXPA04006572A (es) | Terapia de combinacion antivirica. | |
MY137620A (en) | Therapeutic treatment | |
MY141007A (en) | Use of an alpha-2-delta ligand for the treatment of luts | |
UA88655C2 (ru) | S-миртазапин для лечения прилива крови | |
NO20053626L (no) | Blanding omfattende en kombinasjon av en aromataseinhibitor, et progestin og et ostrogen for anvendelse av behandling av endomeriose | |
DK1635843T3 (da) | Terapi, der omfatter dienogest for hormonerstatning og depression | |
SI1526856T1 (sl) | Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka | |
PT1713438E (pt) | Sabonete medicinal | |
DE602005021978D1 (de) | Quecksilberfreie zusammensetzungen und strahlungsquellen damit | |
IS7204A (is) | Notkun á (11ß, 17ß)-11-(1,3-bensódíoxól-5-ýl)-17-hýdroxý-17-(1-própýnýl)-estra-4,9-díen-3-ón við meðhöndlun á stórvægilegri geðlægðartruflun | |
ATE377020T1 (de) | Kristallines gamma-lacton der17beta-hydroxy- | |
WO2003084521A3 (en) | Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy | |
WO2003039455A3 (en) | Methods of treating endometreosis | |
CY1110463T1 (el) | Θεραπεια ορμονικης αντικαταστασης και καταθλιψης που περιλαμβανει διενογεστη | |
GEU20071328Y (en) | Intrastromal cornea arch |